参考文献/References:
[1] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2022)[J].中国全科医学,2023,26(14):1671-1691.
[2] 中华中医药学会.骨质疏松性骨折中医诊疗指南[J].中医正骨,2023,35(1):1-9.
[3] 海云翔,巩彦龙,宋敏,等.细胞程序性死亡在骨质疏松症中的研究进展[J].中国骨质疏松杂志,2023,29(1):89-94.
[4] COOKSON B T,BRENNAN M A.Pro-inflammatory programmed cell death[J].Trends Microbiol,2001,9(3):113-114.
[5] 麻永胜,蒋宜伟,宋重东,等.细胞焦亡与骨质疏松症关系研究[J].中国骨质疏松杂志,2023,29(8):1192-1196.
[6] 朱礼丰,王文驰,刘强,等.淫羊藿苷防治骨质疏松症的分子机制[J].中国组织工程研究,2026,30(35):9248-9257.
[7] 罗作娅,吴筱枫.骨痿证治理论源流探析[J].江西中医药大学学报,2025,37(5):4-8.
[8] 郭超,赵灿斌,李晓阳,等.中医药通过干预细胞焦亡治疗骨质疏松症的研究进展[J].中国民间疗法,2024,32(6):111-115.
[9] 高向明,周明旺,王晓萍,等.近10余年中医药治疗骨质疏松的回顾性分析[J].中国骨质疏松杂志,2023,29(5):724-728.
[10] 安国俊,张起.中医药治疗骨质疏松症研究进展[J].光明中医,2023,38(18):3662-3666.
[11] 张博然,李宁,段海婧,等.NLRP3炎症小体介导的细胞焦亡在骨缺损修复中的作用及中药调控研究进展[J].甘肃中医药大学学报,2026,43(1):86-93.
[12] 薛云,黄俊卿,赵宇,等.中药活性成分靶向软骨细胞焦亡调控骨关节炎的研究进展[J].中医药导报,2026,32(2):149-156.
[13] 苏辉.骨碎补对去卵巢骨质疏松模型大鼠NLRP3/GSDMD/Caspase-1焦亡通路影响及脂毒性作用机制[D].济南:山东中医药大学,2023.
[14] 邓小磊.基于NF-κB/NLRP3/Caspase-1介导的细胞焦亡探讨补正续骨丸治疗SONFH的机制[D].沈阳:辽宁中医药大学,2024.
[15] 程丽丽,黄传兵,陈君洁,等.重骨颗粒干预膝骨关节炎大鼠细胞焦亡的机制[J].中国骨质疏松杂志,2024,30(9):1317-1322.
[16] GAO W,WANG X,ZHOU Y,et al.Autophagy,ferroptosis,pyroptosis,and necroptosis in tumor immunotherapy[J].Signal Transduct Target Ther,2022,7(1):196.
[17] 杨小瑞,曹林忠,胡康一,等.细胞焦亡在骨代谢异常疾病中的研究[J].中国骨质疏松杂志,2024,30(1):124-128.
[18] YU Z W,ZHANG J,LI X,et al.A new research hot spot:the role of NLRP3 inflammasome activation,a key step in pyroptosis,in diabetes and diabetic complications[J].Life Sci,2020,240:117138.
[19] ZHANG K J,WU Q,JIANG S M,et al.Pyroptosis:a new frontier in kidney diseases[J].Oxid Med Cell Longev,2021,2021:6686617.
[20] 王佳慧,梁欢,于影,等.细胞焦亡与心血管疾病的研究进展[J].生理学报,2021,73(2):329-341.
[21] RAO Z,ZHU Y,YANG P,et al.Pyroptosis in inflammatory diseases and cancer[J].Theranostics,2022,12(9):4310-4329.
[22] SHI J,ZHAO Y,WANG K,et al.Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death[J].Nature,2015,526(7575):660-665.
[23] 李磊,郑怀亮,寇玉,等.淫羊藿苷诱导骨髓间充质干细胞成骨细胞分化的研究[J].中华中医药杂志,2018,33(6):2599-2601.
[24] 李烨,肖亚平,李晶晶,等.淫羊藿对骨髓间充质干细胞影响的研究进展[J].中国药学杂志,2017,52(24):2137-2140.
[25] WU D,CLINE-SMITH A,SHASHKOVA E,et al.T-cell mediated inflammation in postmenopausal osteoporosis[J].Front Immunol,2021,12:687551.
[26] WANG S,WANG H,FENG C,et al.The regulatory role and therapeutic application of pyroptosis in musculoskeletal diseases[J].Cell Death Discov,2022,8(1):492.
[27] WU Y,GAN D,LIU Z,et al.Osteocytes:master orchestrators of skeletal homeostasis,remodeling,and osteoporosis pathogenesis[J].Front Cell Dev Biol,2025,13:1670716.
[28] LUO J,CHEN H,WANG G,et al.CGRP-loaded porous microspheres protect BMSCs for alveolar bone regeneration in the periodontitis microenvironment[J].Adv Healthc Mater,2023,12(28):e2301366.
[29] 张勇杰,曹林忠,尚征亚,等.基于骨髓间充质干细胞焦亡探讨中医药防治激素性股骨头坏死的研究进展[J].风湿病与关节炎,2024,13(4):62-66.
[30] 金红,聂元文.颞下颌关节滑液中IL-1β、IL-18、NLRP3以及Caspase-1水平检测在颌骨成骨细胞焦亡中的意义[J].中国医药科学,2024,14(21):8-11.
[31] 陈梓赟,顾新华.NLRP3炎症小体对种植体植入的影响[J].浙江大学学报(医学版),2023,52(1):126-131.
[32] ZHANG J,WEI K.Necrosulfonamide reverses pyroptosis-induced inhibition of proliferation and differentiation of osteoblasts through the NLRP3/caspase-1/GSDMD pathway[J].Exp Cell Res,2021,405(2):112648.
[33] CHEN Q,LIU X,WANG D,et al.Periodontal inflammation-triggered by periodontal ligament stem cell pyroptosis ex-acerbates periodontitis[J].Front Cell Dev Biol,2021,9:663037.
[34] TAO H,LI W,ZHANG W,et al.Urolithin A suppresses RANKL-induced osteoclastogenesis and postmenopausal osteoporosis by,suppresses inflammation and downstream NF-κB activated pyroptosis pathways[J].Pharmacol Res,2021,174:105967.
[35] DAVIS B K,WEN H,TING J P Y.The inflammasome NLRs in immunity,inflammation,and associated diseases[J].Annu Rev Immunol,2011,29:707-735.
[36] TANG H,DU Y,TAN Z,et al.METTL14-mediated HOXA5 m(6)A modification alleviates osteoporosis via promoting WNK1 transcription to suppress NLRP3-dependent macrophage pyroptosis[J].J Orthop Translat,2024,48:190-203.
[37] 欧斌.白藜芦醇抑制IL-1β诱导髓核细胞活化NF-κB[J].按摩与康复医学,2018,9(21):47-48.
[38] 蒋伟宇,胡旭栋,陈云琳,等.白藜芦醇抑制脊髓损伤兔的NLRP3炎症小体活化[J].中国临床药理学与治疗学,2020,25(8):850-856.
[39] 邹玉莲,陈朝沛,黄海霞,等.白藜芦醇在炎症微环境下促进骨髓间充质干细胞的成骨分化[J].中国组织工程研究,2026,30(7):1669-1678.
[40] 徐娟,周伟伟,王清芝,等.白藜芦醇通过FGFR1/TLR4/NLRP3炎症小体途径减轻牙周炎的研究[J].北京口腔医学,2025,33(4):242-250.
[41] AHMAD HAIRI H,JAYUSMAN P A,SHUID A N.Revisiting resveratrol as an osteoprotective agent:molecular evidence from in vivo and in vitro studies[J].Biomedicines,2023,11(5):1453.
[42] PANDEY S N,BABU M A,GOYAL K,et al.Targeting NLRP3 inflammasome with curcumin:mechanisms and therapeutic promise in chronic inflammation[J].Inflammo-pharmacology,2025,33(10):5667-5687.
[43] 左春月,李猛,靳晓飞,等.黄芪甲苷干预的神经干细胞外泌体通过抑制经典细胞焦亡途径减轻缺血性脑卒中大鼠脑损伤[J].中国病理生理杂志,2025,41(2):277-286.
[44] 邵帅,鲁美丽,高秀秋,等.黄芪甲苷对脂多糖诱导的巨噬细胞炎症反应及核因子κB受体活化因子配体/骨保护素系统表达的影响[J].中国医科大学学报,2022,51(4):294-300.
[45] 蒋惠,王长虹.黄芪皂苷类成分的生物合成、体内外转化、药理作用及质量控制研究进展[J].上海中医药杂志,2025,59(10):80-93.
[46] ZHONG L,XU Z,PENG Y,et al.Therapeutic mechanisms of icariin in intervertebral disc degeneration:a critical narrative review[J].Biochem Biophys Rep,2025,42:102047.
[47] 史纪元,姬乐,武世勋,等.淫羊藿苷通过抑制NLRP3炎性小体和Caspase-1通路减轻骨关节炎[J].世界中医药,2021,16(18):2706-2713.
[48] 龚一昕,刘尚全,袁媛,等.淫羊藿次苷Ⅱ通过p38MAPK调控成骨细胞护骨素表达的体外研究[J].安徽医科大学学报,2016,51(12):1790-1794.
[49] 翟远坤,王鸣刚,李志忠,等.淫羊藿苷含药血清对体外培养骨髓间充质干细胞增殖及成骨性分化的影响[J].中华中医药杂志,2012,27(2):480-484.
[50] 张锦明,田滢舟,赵玲,等.淫羊藿苷促进骨髓间充质干细胞成骨分化缓解小鼠骨质疏松的机制[J].中国组织工程研究,2022,26(19):2991-2996.
[51] 柳骜飞,杨朔.淫羊藿苷调节骨代谢作用机制研究进展[J].亚太传统医药,2026,22(3):252-256.
[52] 李向洲,邢涛,钱朝良,等.NLRP3炎症小体在骨关节疾病中的作用及中医药干预进展[J].中国实验方剂学杂志,2023,29(18):241-250.
[53] 刘波,谢珍,吴琪,等.二仙汤及其拆方对去卵巢大鼠骨质疏松症的影响[J].中华中医药学刊,2018,36(9):2082-2085.
[54] YIN W,LIU S,DONG M,et al.A new NLRP3 inflammasome inhibitor,dioscin,promotes osteogenesis[J].Small,2020,16(1):e1905977.
[55] 王瑛,胡婷婷,付燕,等.仙茅苷下调ROS/NLRP3途径对大鼠骨髓单核细胞增殖及向破骨细胞分化的影响[J].中华骨质疏松和骨矿盐疾病杂志,2023,16(6):568-578.
[56] 郑升鹏,曾志奎,姜自伟,等.基于数据挖掘的骨质疏松症用药规律研究[J].中华中医药学刊,2018,36(2):341-344.
[57] GIORDANI C,MATACCHIONE G,GIULIANI A,et al.Pro-osteogenic and anti-inflammatory synergistic effect of ortho-silicic acid,vitamin K2,curcumin,polydatin and quercetin combination in young and senescent bone marrow-derived mesenchymal stromal cells[J].Int J Mol Sci,2023,24(10):8820.
[58] LUO X,BAO X,WENG X,et al.The protective effect of quercetin on macrophage pyroptosis via TLR2/Myd88/NF-κB and ROS/AMPK pathway[J].Life Sci,2022,291:120064.
[59] 舒晓春,刘君静,朱丹华,等.不同浓度的骨碎补总黄酮对大鼠骨髓间充质干细胞向成骨细胞分化的影响[J].中国病理生理杂志,2010,26(7):1261-1264.
[60] 陈元良,张寿,钟海波,等.骨碎补总黄酮对骨性关节炎血清IL-1、IL-8及TNF-a表达的影响[J].陕西中医,2013,34(9):1251-1253.
[61] 张芷妍,濮子彧,张明桃,等.中药骨碎补化学成分和药理作用研究进展[J].南京中医药大学学报,2025,41(8):1114-1126.
[62] 刘朝晖.骨碎补抗骨质疏松症的网络药理学研究及其单体柚皮苷对破骨细胞极化影响的初步探究[D].天津:天津医科大学,2021.
[63] ANG E S M,YANG X,CHEN H,et al.Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-κB and ERK activation[J].FEBS Lett,2011,585(17):2755-2762.
[64] 苏束束.柚皮苷通过NF-κB和p38MAPK通路抑制LPS诱导的破骨细胞生成[D].锦州:锦州医科大学,2024.
[65] LI Z,GAO K,WANG M,et al.Naringin inhibits the osteoblast-osteoclast pyroptosis cascade reaction mediated by accumulated bone marrow adipose tissue in the treatment of postmenopausal osteoporosis[J].J Orthop Translat,2025,55:323-338.
[66] GUAN H,LUO W,BAO B,et al.A comprehensive review of rosmarinic acid:from phytochemistry to pharmacology and its new insight[J].Molecules,2022,27(10):3292.
[67] FENG S,MA R,HUANG Y,et al.Rosmarinic acid ameliorates type 2 diabetic osteoporosis by reducing NLRP3 expression and alleviating osteoblast pyroptosis via the FOXO1/TXNIP signaling pathway[J].J Agric Food Chem,2025,73(26):16557-16572.
[68] LI Q,TAO X,ZHANG Y.Rosmarinic acid alleviates diabetic osteoporosis by suppressing the activation of NLRP3 inflammasome in rats[J].Physiol Int,2022,109(1):46-57.
[69] 曹淑娜,曹梦启,吕振豪,等.黄连炮制历史沿革、化学成分及药理作用研究进展[J].辽宁中医药大学学报,2026,28(6):31-39.
[70] AN C,WU Y,WU J,et al.Berberine ameliorates pulmonary inflammation in mice with influenza viral pneumonia by inhibiting NLRP3 inflammasome activation and gasdermin D-mediated pyroptosis[J].Drug Dev Res,2022,83(7):1707-1721.
[71] CHEN T,AI G,LIANG G,et al.Mitigation of inflammatory bowel disease-related osteoporosis by oxyberberine:insights into the RANKL/NF-κB signaling pathway[J].Biomed Pharmacother,2024,174:116523.
[72] 黄飞日,苏忠良,杨知帆,等.去甲斑蝥素对去势骨质疏松症小鼠骨微结构影响的研究[J].浙江医学,2020,42(14):1533-1535.
[73] YANG G,XU H,YAO M,et al.Norcantharidin ameliorates estrogen deficient-mediated bone loss by attenuating the activation of extracellular signal-regulated kinase/ROS/NLRP3 inflammasome signaling[J].Front Pharmacol,2022,13:1019478.
[74] 张友,陈弘林,刘宇,等.肉豆蔻酸延缓黄韧带成纤维细胞/骨髓间充质干细胞衰老调控成骨的机制[J].中国骨质疏松杂志,2025,31(10):1413-1421.
[75] 陈弘林,余富勇,尚奇,等.龟甲提取物干扰NF-κB-NLRP3炎症体正反馈回路改善老年性骨质疏松的研究[J].中华中医药杂志,2023,38(5):2437-2443.
相似文献/References:
[1]李林军.应用膨胀式椎弓根螺钉内固定治疗合并骨质疏松的
胸腰椎退行性疾病[J].中医正骨,2015,27(08):49.
[2]韩艳,温利平,刘娜,等.补肾活血方对去卵巢大鼠骨代谢及骨密度的影响[J].中医正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(补肾活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(07):7.
[3]李学朋,朱立国.骨疏康胶囊对去卵巢大鼠骨小梁的影响[J].中医正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康胶囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(07):12.
[4]陈冠军,陈扬,庄汝杰.可灌注骨水泥椎弓根螺钉系统
在老年腰椎疾患手术中的应用[J].中医正骨,2015,27(02):40.
[5]王丹辉,贲越,韩梅.林蛙油治疗绝经后骨质疏松症的临床研究[J].中医正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(07):27.
[6]黄建华,黄建武,李慧辉,等.加味左归丸对绝经后骨质疏松症肝肾不足证
患者骨密度的影响[J].中医正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(07):19.
[7]项旻,杨虹,林爱菊,等.绝经后2型糖尿病患者骨质疏松与血微量元素的关系研究[J].中医正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(07):20.
[8]史晓林,李春雯,张志强.弱阳离子磁珠分离技术和基质辅助激光解吸电离飞行时间质谱技术在原发性Ⅰ型骨质疏松症血清标志蛋白筛选中的应用[J].中医正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(07):5.
[9]李明,徐明雄,冯左基,等.自拟壮骨方治疗绝经后骨质疏松症的疗效及作用机制研究[J].中医正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(07):21.
[10]陈俊杰,李晴晴,夏瑢.脂代谢及血清内脂素水平与绝经后骨质疏松症的
相关性研究[J].中医正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(07):16.